Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Investors Bancorp Inc. (Amendment)SC 13G/A - Investors Bancorp, Inc. (0001594012) (Subject)
- SECSEC Form 15-12B filed by Investors Bancorp Inc.15-12B - Investors Bancorp, Inc. (0001594012) (Filer)
- 13D/GSEC Form SC 13G filed by Investors Bancorp Inc.SC 13G - Investors Bancorp, Inc. (0001594012) (Subject)
- INSIDERSEC Form 4: Albanese Robert C disposed of 107,419 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Byrnes Doreen R disposed of 116,694 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Spengler Richard disposed of 635,972 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Burke P. Sean covered exercise/tax liability with 27,700 shares and disposed of 148,409 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Kalamaras Paul covered exercise/tax liability with 29,229 shares and disposed of 338,724 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Ward James H Iii disposed of 436,400 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Harmon John E Sr disposed of 1,100 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Cosgrove William V. disposed of 147,880 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Cummings Kevin covered exercise/tax liability with 64,750 shares and disposed of 1,667,043 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Garibaldi James J. disposed of 66,980 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Cama Domenick A disposed of 1,332,287 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Bone Dennis M disposed of 155,674 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Stathoulopoulos Paul disposed of 215,430 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- INSIDERSEC Form 4: Siekerka Michele N disposed of 172,699 shares, closing all direct ownership in the company4 - Investors Bancorp, Inc. (0001594012) (Issuer)
- SECInvestors Bancorp Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Investors Bancorp, Inc. (0001594012) (Filer)
- SECSEC Form 25-NSE filed by Investors Bancorp Inc.25-NSE - Investors Bancorp, Inc. (0001594012) (Subject)
- SECSEC Form 10-K/A filed by Investors Bancorp Inc. (Amendment)10-K/A - Investors Bancorp, Inc. (0001594012) (Filer)
- NEWSThe Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcelHere's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Theravance Announces Phase 3 Data For Ampreloxetine Showing Clear Benefit In Multiple System Atrophy Patients Theravance Biopharma, Inc. (NASDAQ:TBPH) announced results from the second Phase 3 study, assessing the durability of clinical effect of ampreloxetine compared to placebo for the treatment of symptomatic neurogenic orthostatic hypotension. The primary endpoint was not statistically significant for the overall population of patients, which included patients with Parkinson's disease, pure autonomic failure and multiple system atrophy. Yet the pre-specified subgroup analysis by disease
- PRArcus Biosciences Set to Join S&P SmallCap 600NEW YORK, April 4, 2022 /PRNewswire/ -- Arcus Biosciences Inc. (NYSE:RCUS) will replace Investors Bancorp Inc. (NASD:ISBC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 7. S&P 500 constituent Citizens Financial Group Inc. (NYSE:CFG) is acquiring Investors Bancorp in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 7, 2022 S&P SmallCap 600 Addition Arcus Biosciences RCUS Health Care S&P SmallCap 600 Deletion Investors Bancorp ISBC Financials For m
- NEWS'Arcus Biosciences Set to Join S&P SmallCap 600,' Replacing Investors Bancorp -S&P Dow Jones Indiceshttps://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220404-1451281/1451281_isbc6.pdf
- SECInvestors Bancorp Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Investors Bancorp, Inc. (0001594012) (Filer)
- PRCitizens Financial Group and Investors Bancorp Announce Transaction Close Date for MergerPROVIDENCE, R.I. and SHORT HILLS, N.J., April 4, 2022 /PRNewswire/ -- Citizens Financial Group, Inc. (NYSE:CFG) ("Citizens") and Investors Bancorp, Inc. (NASDAQ:ISBC) ("Investors") today announce that the expected close date of the previously announced merger between the two companies is April 6, 2022, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. Citizens and Investors previously announced that regulatory approval for this merger was received from the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency. About Citizens Financial Group, Inc. Citizens Financial Group, Inc. is
ISBC FAQ
6 questionsWhat does Investors Bancorp Inc. do?
Investors Bancorp, Inc. operates as the bank holding company for Investors Bank that provides various banking products and services to individuals and businesses in the United States. Its deposit products include savings, checking, and money market accounts. The company's loan portfolio comprises multi-family, commercial real estate, commercial and industrial, and construction loans; one-to four-family residential mortgage loans secured by one-to four-family residential real estate; and consumer and other loans primarily consisting of home equity loans, and home equity lines of credit, as...Where does ISBC stock trade?
Investors Bancorp Inc. (ISBC) is listed on NASDAQ.What sector and industry is ISBC in?
Investors Bancorp Inc. operates in the Finance sector, Savings Institutions industry.What are analysts saying about ISBC?
Investors Bancorp Inc. has had 4 recent analyst actions on file. The most recent action was from Wells Fargo: Equal-Weight with a $1600.00 price target on 2021-10-07. Recent price targets range from $1450.00 to $1750.00.What companies are similar to ISBC?
Notable peers in the same industry include HSBC (HSBC Holdings plc.), PBCT (People's United Financial Inc.), AX (Axos Financial Inc.), TFSL (TFS Financial Corporation), EBC (Eastern Bankshares Inc.). Compare ISBC side-by-side with any of them on Quantisnow.How can I track ISBC on Quantisnow?
Quantisnow aggregates Investors Bancorp Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISBC to receive live email and push alerts on every new disclosure.